PMA supplement
P050042 S041: Alinity i Anti-HCV
FDA PMA supplement · Normal 180 Day Track No User Fee · Abbott Laboratories, Inc.
Key facts
| Original PMA | P050042 |
|---|---|
| Supplement number | S041 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Alinity i Anti-HCV |
| Generic name | Assay, enzyme linked immunosorbent, hepatitis c virus |
| Applicant | Abbott Laboratories, Inc. |
| Product code | MZO |
| Received date | Mar 16, 2020 |
| Decision date | May 23, 2020 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: